Targeting the interleukin-11 receptor α in metastatic prostate cancer: A first-in-man study

Cancer immunotherapy: a paradigm shift for prostate cancer treatment

(2012) Dev Karan et al.   Nature Reviews Urology

Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy

(2012) Howard I. Scher et al.   NEW ENGLAND JOURNAL OF MEDICINE

The binding characteristics of a cyclic nonapeptide, c(CGRRAGGSC), in LNCaP human prostate cancer cells

(2012) CHEN GU et al.   Oncology Letters

Abiraterone and Increased Survival in Metastatic Prostate Cancer

(2011) Johann S. de Bono et al.   NEW ENGLAND JOURNAL OF MEDICINE

Vascular ligand-receptor mapping by direct combinatorial selection in cancer patients

(2011) F. I. Staquicini et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A Peptidomimetic Targeting White Fat Causes Weight Loss and Improved Insulin Resistance in Obese Monkeys

(2011) K. F. Barnhart et al.   Science Translational Medicine

Significant and Sustained Antitumor Activity in Post-Docetaxel, Castration-Resistant Prostate Cancer With the CYP17 Inhibitor Abiraterone Acetate

(2010) Alison H.M. Reid et al.   JOURNAL OF CLINICAL ONCOLOGY

Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial

(2010) Johann Sebastian de Bono et al.   LANCET

Leveraging Molecular Heterogeneity of the Vascular Endothelium for Targeted Drug Delivery and Imaging

(2010) Renata Pasqualini et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

The Interleukin-11 Receptor   as a Candidate Ligand-Directed Target in Osteosarcoma: Consistent Data from Cell Lines, Orthotopic Models, and Human Tumor Samples

(2009) V. O. Lewis et al.   CANCER RESEARCH

Phase I Study of Concurrent Weekly Docetaxel and Repeated Samarium-153 Lexidronam in Patients With Castration-Resistant Metastatic Prostate Cancer

(2009) Shi-Ming Tu et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase I Study of Samarium-153 Lexidronam With Docetaxel in Castration-Resistant Metastatic Prostate Cancer

(2009) Michael J. Morris et al.   JOURNAL OF CLINICAL ONCOLOGY

Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer

(2009) C. Tran et al.   SCIENCE

Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group

(2008) Howard I. Scher et al.   JOURNAL OF CLINICAL ONCOLOGY

A Ligand Peptide Motif Selected from a Cancer Patient Is a Receptor-Interacting Site within Human Interleukin-11

(2008) Marina Cardó-Vila et al.   PLoS One

Beyond Receptor Expression Levels: The Relevance of Target Accessibility in Ligand-Directed Pharmacodelivery Systems

(2008) Michael G. Ozawa et al.   TRENDS IN CARDIOVASCULAR MEDICINE